Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression.
Acta Pharm Sin B
; 11(9): 2655-2669, 2021 Sep.
Article
em En
| MEDLINE
| ID: mdl-34589387
Antitumor peptide; FP, fluorescence polarization; ITC, isothermal titration calorimetry; MDM2; MDM2, murine double minute 2; MDMX; MDMX, murine double minute X; P53; PMI, P53âMDM2/MDMX inhibitor; SAR, structureâactivity relationship; SPR, surface plasmon resonance; Systematic mutational analysis
Texto completo:
1
Bases de dados:
MEDLINE
Idioma:
En
Revista:
Acta Pharm Sin B
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
China